Intellia Therapeutics Inc (NTLA) Insider Trading
- $13,217,886.00
- $277,561,962.62
- March 4, 2024
- John M Leonard
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 27, 2020 | CEO | 35,000 | $38.57 | Sell | $1,349,950.00 | |
| Nov. 25, 2020 | CEO | 50,000 | $36.00 | Sell | $1,800,000.00 | |
| Nov. 18, 2020 | EVP | 624 | $35.00 | Sell | $21,840.00 | |
| Nov. 16, 2020 | CEO | 20,000 | $34.00 | Sell | $680,000.00 | |
| Nov. 16, 2020 | EVP | 6,029 | $34.29 | Sell | $206,734.41 | |
| Nov. 4, 2020 | EVP | 3,364 | $28.00 | Sell | $94,192.00 | |
| Nov. 4, 2020 | CEO | 50,000 | $26.00 | Sell | $1,300,000.00 | |
| Oct. 15, 2020 | EVP | 5,615 | $24.20 | Sell | $135,883.00 | |
| Oct. 7, 2020 | CEO | 5,000 | $21.83 | Sell | $109,150.00 | |
| Sept. 15, 2020 | EVP | 5,615 | $21.04 | Sell | $118,139.60 | |
| Aug. 18, 2020 | EVP | 5,615 | $21.00 | Sell | $117,915.00 | |
| Aug. 6, 2020 | CEO | 5,000 | $21.83 | Sell | $109,150.00 | |
| July 15, 2020 | EVP | 5,615 | $22.70 | Sell | $127,460.50 | |
| July 1, 2020 | CEO | 5,000 | $21.83 | Sell | $109,150.00 | |
| June 16, 2020 | EVP | 5,615 | $21.00 | Sell | $117,915.00 | |
| June 3, 2020 | CEO | 5,000 | $21.83 | Sell | $109,150.00 | |
| May 26, 2020 | EVP | 5,615 | $21.21 | Sell | $119,094.15 | |
| March 6, 2019 | EVP | 7,500 | $15.72 | Buy | $117,900.00 | |
| July 16, 2018 | Director | 6,686 | $31.17 | Sell | $208,402.62 | |
| June 19, 2018 | Director | 6,686 | $27.96 | Sell | $186,940.56 | |
| May 16, 2018 | Director | 6,686 | $25.04 | Sell | $167,417.44 | |
| May 14, 2018 | Insider | 8,400 | $24.00 | Sell | $201,600.00 | |
| March 20, 2018 | Director | 39,245 | $23.87 | Sell | $936,778.15 | |
| Jan. 29, 2018 | Major Shareholder | 550,645 | $26.78 | Sell | $14,746,273.10 | |
| Dec. 12, 2017 | Major Shareholder | 1,523,000 | $18.30 | Sell | $27,870,900.00 | |
| Dec. 8, 2017 | CEO | 336,783 | $20.78 | Sell | $6,998,350.74 | |
| Dec. 6, 2017 | CEO | 111,500 | $20.34 | Sell | $2,267,910.00 | |
| July 11, 2017 | Major Shareholder | 150,000 | $16.24 | Sell | $2,436,000.00 | |
| March 10, 2017 | Director | 21,132 | $13.91 | Sell | $293,946.12 | |
| May 11, 2016 | Major Shareholder | 277,777 | $18.00 | Buy | $4,999,986.00 | |
| May 11, 2016 | Insider | 200,000 | $18.00 | Buy | $3,600,000.00 | |
| May 11, 2016 | Director | 250,000 | $18.00 | Buy | $4,500,000.00 |
Insiders are both buying and selling Intellia Therapeutics Inc stock.
The insider traders at Intellia Therapeutics Inc are: John M Leonard, Jose E Rivera, Jean Francois Formela, Glenn Goddard, David Lebwohl, Laura Sepp-Lorenzino, Jose E. Rivera, Muna Bhanji, Andrew Schiermeier, Eliana Clark, Institutes For Biomed Novartis, John F Crowley, John M. Leonard, Nessan Bermingham, Caroline Dorsa, Carl L Gordon, Caribou Biosciences, Inc., Bros. Advisors Lp Baker, Venture Fund Ix L.P. Atlas, James Basta, and Perry A Karsen
The most active insider trader at Intellia Therapeutics Inc is John M Leonard with 19 trades.
Jean Francois Formela has sold the most Intellia Therapeutics Inc stock with a total value of $207,869,472.85.
Institutes For Biomed Novartis has bought the most Intellia Therapeutics Inc stock with a total value of $9,999,972.00.
The most recent insider trade for Intellia Therapeutics Inc was on March 4, 2024.
The single biggest insider buy for Intellia Therapeutics Inc was from Institutes For Biomed Novartis with a total value of $4,999,986.00 on May 11, 2016.
The single biggest insider sell for Intellia Therapeutics Inc was from Jean Francois Formela with a total value of $73,449,596.48 on June 28, 2021.